Volume 121; Issue 3-part-P2

American Heart Journal

Volume 121; Issue 3-part-P2
1

Introduction

Giuseppe Mancia, Jacques de Champlain
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 210 KB
english, 1991
2

Cardiovascular risk factors and the effects of intervention

Peter Sleight
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 611 KB
english, 1991
3

Reversal of cardiac and vascular hypertrophy by antihypertensive therapy

Lennart Hansson
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 424 KB
english, 1991
4

Ambulatory blood pressure monitoring in the evaluation of drug efficacy

Eoin O'Brien, Kevin O'Malley, John Cox, Alice Stanton
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 1.02 MB
english, 1991
5

Clinical pharmacology of vasodilatory β-blocking drugs

Robin G. Shanks
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 714 KB
english, 1991
6

Vasodilatory β-blockers: Systemic and regional hemodynamic effects

Edward D. Frohlich
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 753 KB
english, 1991
7

Angina, ischemia, and effort tolerance with vasodilating β-blockers

Henry J. Dargie, S. Grant, J. McLenachan
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 364 KB
english, 1991
8

Efficacy of celiprolol in the elderly hypertensive patient

S.H. Taylor
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 3.64 MB
english, 1991
9

The effects of cardioselective vasodilating β-blockers on lipids

Donald B. Hunninghake
Journal:
American Heart Journal
Year:
1991
Language:
english
File:
PDF, 376 KB
english, 1991